Metges, J. P., Lebot, M. A., Faroux, R., Riaud, F., Gamelin, E., Capitain, O., . . . Grudé, F. (2014). Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: Focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne / Pays de la Loire). Oncologie (Paris).
Citação norma ChicagoMetges, J. P., et al. "Evaluation in Usual Practice of the Bevacizumab-FOLFIRI Combination for the First-line Treatment of Patients With Unresectable Metastatic Colorectal Cancer Treated in 2006: Focus On Resected Patients and Oncogeriatrics: AVASTIN OUEST Cohort of the Observatory of Cancer of the Brittany And Pays De La Loire Areas (Observatoire Dédié Au Cancer Bretagne / Pays De La Loire)." Oncologie (Paris) 2014.
Citação norma MLAMetges, J. P., et al. "Evaluation in Usual Practice of the Bevacizumab-FOLFIRI Combination for the First-line Treatment of Patients With Unresectable Metastatic Colorectal Cancer Treated in 2006: Focus On Resected Patients and Oncogeriatrics: AVASTIN OUEST Cohort of the Observatory of Cancer of the Brittany And Pays De La Loire Areas (Observatoire Dédié Au Cancer Bretagne / Pays De La Loire)." Oncologie (Paris) 2014.